Suneetha Kalam's scientific contributions

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (3)


Fetomaternal outcome in sickle cell hemoglobinopathy in a tertiary care centre of North Kerala, India
  • Article

November 2017

·

65 Reads

·

6 Citations

International Journal of Reproduction Contraception Obstetrics and Gynecology

Smitha D'Couth

·

Suneetha Kalam

Background: Pregnancy is a serious burden to women with sickle cell disease (SCD). Our centre is the only tertiary care referral centre in the public sector which caters to the districts of Wayanad and the Nilgiris which has the maximum prevalence for SCD in South India. Hence this study was conducted to assess complications in pregnancy and maternal and perinatal outcome among women with SCD.Methods: A retrospective observational study was conducted by reviewing the medical records of all the pregnant women with SCD who had delivered in the Department of Obstetrics and Gynecology, Government Medical College, Kozhikode from January 2014 to December 2016.Results: There were 72 antenatal women with SCD during the study period with a prevalence of 0.15%. 54.17% (n = 39) patients were HbSS (sickle cell anemia), 44.44% (n = 32) were HbAS (sickle cell trait) and 1.39% (n = 1) were HbS-β thalassemia trait. There was increased risk of obstetric complications like gestational hypertension (16%), preeclampsia (11.11%), eclampsia (5.56%), HELLP syndrome (4.16%), intrauterine growth retardation (38.89%), and oligohydramnios (18.06%). Medical complications observed were mainly anaemia (76.38%), vasoocclusive crisis (18.05%), acute chest syndrome (5.56%) and infections like urinary tract infection (8.33%) and pneumonia (5.56%). The incidence of low birth weight babies (56.94%), low Apgar score (14.49%) and neonatal ICU admissions (31.88%) were high. There was no maternal mortality, but perinatal mortality was high (6.94%).Conclusion: Pregnancy in SCD is associated with an increased maternal morbidity and high perinatal mortality due to obstetric and medical complications.

Share


Citations (1)


... Despite a tacit consensus on high under 5 mortality caused by SCD in LMICs, there is little empirical data published on the clinical or socio-demographic profile of mortality related to SCD in India and other LMICs. A discussion on mortality might appear as part of clinical profile, treatment outcomes, hospital morbidity surveys (21,22), case reports (23), perinatal outcomes (24,25), or newborn cohort follow-up studies (25,26). Insights into the importance of a social profiling of hospital deaths is exceptional (27)(28)(29). ...

Reference:

A social profile of deaths related to sickle cell disease in India: a case for an ethical policy response
Fetomaternal outcome in sickle cell hemoglobinopathy in a tertiary care centre of North Kerala, India
  • Citing Article
  • November 2017

International Journal of Reproduction Contraception Obstetrics and Gynecology